Natixis’s Express Scripts Holding Company ESRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-1,322,288
Closed -$126M 880
2018
Q3
$126M Buy
1,322,288
+1,271,455
+2,501% +$108M 0.73% 36
2018
Q2
$3.92M Sell
50,833
-21,070
-29% -$1.58M 0.02% 413
2018
Q1
$4.97M Buy
+71,903
New +$5.49M 0.03% 365
2017
Q4
Sell
-482,949
Closed -$30.6M 1337
2017
Q3
$30.6M Buy
482,949
+446,645
+1,230% +$27.8M 0.28% 93
2017
Q2
$2.32M Buy
36,304
+13,029
+56% +$818K 0.03% 314
2017
Q1
$1.53M Sell
23,275
-85,713
-79% -$5.9M 0.02% 342
2016
Q4
$7.5M Buy
+108,988
New +$7.81M 0.08% 217
2016
Q3
Sell
-16,156
Closed -$1.23M 585
2016
Q2
$1.23M Buy
+16,156
New +$1.19M 0.02% 252
2015
Q2
Sell
-20,798
Closed -$1.8M 462
2015
Q1
$1.8M Buy
+20,798
New +$1.74M 0.02% 195
2014
Q4
Sell
-3,227
Closed -$228K 448
2014
Q3
$228K Sell
3,227
-50,000
-94% -$3.56M ﹤0.01% 380
2014
Q2
$3.69M Buy
53,227
+4,726
+10% +$333K 0.04% 198
2014
Q1
$3.64M Sell
48,501
-81,900
-63% -$6.13M 0.05% 199
2013
Q4
$9.16M Sell
130,401
-1,100
-0.8% -$71.8K 0.08% 185
2013
Q3
$8.12M Buy
131,501
+4,383
+3% +$283K 0.09% 193
2013
Q2
$7.84M Buy
+127,118
New +$7.65M 0.11% 162

Other funds holding ESRX

Natixis's ESRX Position: Q4 2018 in Review

Natixis sold out of Express Scripts Holding Company (ESRX) in Q4 2018, closing a stake of 1,322,288 shares — an estimated $126M sold.

Natixis first reported a position in ESRX in Q2 2013 and held it in 15 quarters. The position peaked at $126M in Q3 2018. 16 funds tracked by Wall St. Rank hold ESRX as of Q4 2018.

  • Natixis reported no remaining Express Scripts Holding Company position as of Q4 2018 after selling out during the quarter.
  • Natixis sold 1,322,288 Express Scripts Holding Company shares in Q4 2018, an estimated $126M.
  • Natixis first reported a position in Express Scripts Holding Company in Q2 2013 and held it in 15 quarters.
  • Natixis's Express Scripts Holding Company position peaked at $126M in Q3 2018.
  • 16 funds tracked by Wall St. Rank held Express Scripts Holding Company as of Q4 2018.

Based on Natixis's 13F filing for Q4 2018, filed 14 Feb 2019.